Michael Okunewitch, an analyst from Maxim Group, maintained the Buy rating on Citius Pharmaceuticals (CTXR – Research Report). The ...
Medicenna Therapeutics Corp (TSE:MDNA) has released an update. Medicenna Therapeutics Corp. has reported promising results from its Phase 1/2 ...
The top-line beat was led by its higher than anticipated sales of Covid-19 vaccine, while its recently approved respiratory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback